The emerging role of ADAM metalloproteinases in immunity

BN Lambrecht, M Vanderkerken… - Nature Reviews …, 2018 - nature.com
Proteolysis is an irreversible physiological process that can result in the termination or
activation of protein function. Many transmembrane proteins that are involved in the cellular …

Targeting ADAM10 in cancer and autoimmunity

TM Smith Jr, A Tharakan, RK Martin - Frontiers in immunology, 2020 - frontiersin.org
Generating inhibitors for AD isintegrin A nd M etalloproteinase 10 (ADAM10), a zinc-
dependent protease, was heavily invested in by the pharmaceutical industry starting over 20 …

ABHD17 regulation of plasma membrane palmitoylation and N-Ras-dependent cancer growth

JR Remsberg, RM Suciu, NA Zambetti… - Nature chemical …, 2021 - nature.com
Multiple Ras proteins, including N-Ras, depend on a palmitoylation/depalmitoylation cycle to
regulate their subcellular trafficking and oncogenicity. General lipase inhibitors such as …

Synaptic dysfunction in early phases of Alzheimer's Disease

S Pelucchi, F Gardoni, M Di Luca, E Marcello - Handbook of clinical …, 2022 - Elsevier
The synapse is the locus of plasticity where short-term alterations in synaptic strength are
converted to long-lasting memories. In addition to the presynaptic terminal and the …

The role of ADAM10 in Alzheimer's disease

XZ Yuan, S Sun, CC Tan, JT Yu… - Journal of Alzheimer's …, 2017 - content.iospress.com
As a member of the A Disintegrin And Metalloproteinase (ADAM) family, ADAM10 has been
identified as the constitutive α-secretase in the process of amyloid-β protein precursor …

Phosphorylation signaling in APP processing in Alzheimer's disease

T Zhang, D Chen, TH Lee - International journal of molecular sciences, 2019 - mdpi.com
The abnormal accumulation of amyloid-β (Aβ) in the central nervous system is a hallmark of
Alzheimer's disease (AD). The regulation of the processing of the single-transmembrane …

Dendritic spines in Alzheimer's disease: how the actin cytoskeleton contributes to synaptic failure

S Pelucchi, R Stringhi, E Marcello - International journal of molecular …, 2020 - mdpi.com
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by Aβ-driven
synaptic dysfunction in the early phases of pathogenesis. In the synaptic context, the actin …

Alpha-secretase ADAM10 regulation: insights into Alzheimer's disease treatment

R Peron, IP Vatanabe, PR Manzine, A Camins… - Pharmaceuticals, 2018 - mdpi.com
ADAM (a disintegrin and metalloproteinase) is a family of widely expressed, transmembrane
and secreted proteins of approximately 750 amino acids in length with functions in cell …

[HTML][HTML] The Golgi apparatus: A voyage through time, structure, function and implication in neurodegenerative disorders

AG Mohan, B Calenic, NA Ghiurau, RM Duncea-Borca… - Cells, 2023 - mdpi.com
This comprehensive review article dives deep into the Golgi apparatus, an essential
organelle in cellular biology. Beginning with its discovery during the 19th century until …

[HTML][HTML] ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker

PR Manzine, M Ettcheto, A Cano, O Busquets… - Biomedicine & …, 2019 - Elsevier
Alzheimer's disease (AD) represents a global burden in the economics of healthcare
systems. Amyloid-β (Aβ) peptides are formed by amyloid-β precursor protein (AβPP) …